EU launches legal action against vaccine maker AstraZeneca
by Associated Press
The reason for the legal action was that "some terms of the contract have not been respected"
The European Union’s executive branch said on Apr. 26 that it has launched legal action against coronavirus vaccine-maker AstraZeneca for failing to respect the terms of its contract with the 27-nation bloc.
The AstraZeneca vaccine has been central to Europe’s immunization campaign, and a linchpin in the global strategy to get vaccines to poorer countries. But the slow pace of deliveries has frustrated the Europeans and they have held the company responsible for partly delaying their vaccine rollout.
European Commission spokesman Stefan De Keersmaecker said that Brussels launched the legal action against AstraZeneca on Apr. 23 “on the basis of breaches of the advance purchase agreement.”
He said the reason for the legal action was that “some terms of the contract have not been respected” and that “the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.”
AstraZeneca’s contract with the EU, which was signed by the Commission on behalf of the member countries last August, foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.
The British-Swedish drugmaker had hoped to deliver 80 million doses of that in the first quarter of 2021, but only 30 million were sent. According to the Commission, the company is now set to provide 70 million doses in the second quarter, rather than the 180 million it had promised.
Last week, Commission President Ursula von der Leyen announced that a new vaccine contract is set to be concluded with BioNTech-Pfizer for 1.8 billion doses for the 2021-23 period. She said the deal will ensure doses for booster shots, vaccines adapted to new variants, and, potentially, vaccines for children and teenagers.
Von der Leyen said that the EU, home to around 450 million people, has “already passed 123 million vaccinations” and is on track to have vaccinated 70% of all adults by July. Previously the target had been September.
